repotrectinib

This Drug Candidate Could Be a Winner for Bristol Myers
Motley Fool
Mon, 06/12/23 - 10:18 am
Bristol Myers Squibb
repotrectinib
non-small cell lung cancer
metastatic small cell lung cancer
Foundation Medicine to collaborate with Bristol Myers Squibb on companion diagnostic for solid tumors
LabPulse
Tue, 04/11/23 - 07:25 pm
Bristol Myers Squibb
Foundation Medicine
diagnostics
FoundationOne
companion diagnostics
repotrectinib
Turning Point looks to challenge Pfizer, Roche with new early data for lead lung cancer drug
Endpoints
Wed, 04/13/22 - 05:37 pm
Turning Point Therapeutics
Pfizer
Roche
repotrectinib
clinical trials
non-small cell lung cancer
Triple meeting – the point of turning to TPX-0022
EP Vantage
Tue, 10/27/20 - 10:32 am
Turning Point Therapeutics
repotrectinib
TPX-0022
non-small cell lung cancer
Turning Point touts positive pivotal NSCLC data, hints at even faster OK — but can it beat Pfizer and Roche?
Endpoints
Wed, 08/19/20 - 12:18 pm
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
clinical trials
Pfizer
Roche
Important catalysts approach for smaller biotechs
EP Vantage
Wed, 06/24/20 - 10:35 am
BeiGene
Turning Point Therapeutics
Intra-Cellular Therapies
Immunovant
Caplyta
Brukinsa
repotrectinib
IMVT-1401
clinical trials
ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR
Fierce Biotech
Mon, 06/3/19 - 11:43 am
ASCO 2019
clinical trials
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
Turning Point sinks on ASCO update for repotrectinib
BioCentury
Fri, 05/31/19 - 11:59 pm
ASCO 2019
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
Almac Diagnostic Services to Develop Companion Diagnostic for TP Therapeutics' Cancer Drug
CP Wire
Wed, 10/24/18 - 10:06 am
Almac Diagnostic Services
TP Therapeutics
repotrectinib
diagnostics
Almac Diagnostic Services to Develop Companion Diagnostic for TP Therapeutics' Cancer Drug
Wed, 10/24/18 - 09:30 am
Almac Diagnostic Services
TP Therapeutics
repotrectinib
TP Therapeutics Secures $80 Million Mezzanine Financing
CP Wire
Fri, 10/19/18 - 11:44 am
TP Therapeutics
non-small cell lung cancer
repotrectinib
TP Therapeutics Secures $80 Million Mezzanine Financing
Fri, 10/19/18 - 09:29 am
TP Therapeutics
non-small cell lung cancer
repotrectinib